BofA raised the firm’s price target on Bunge (BG) to $112 from $95 and keeps a Buy rating on the shares, citing updated earnings forecasts and confidence in synergy realization from the Viterra deal. The firm, which assumes that most of the synergy capture will be materialized by yearend 2027 and market dynamics will improve, raised its 2026-27 EPS forecasts to $8.35 and $10.70, respectively.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
- Bunge Global’s Strong Earnings Growth Potential and Strategic Transformation Drive Buy Rating
- Bunge upgraded to Overweight from Equal Weight at Barclays
- Bunge Global SA Reports Mixed Q3 2025 Results
- Bunge Global Sa’s Mixed Earnings Call Highlights
- Bunge backs FY25 adjusted EPS view $7.30-$7.60, consensus $7.27